Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Gaggero

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cancers|June 10, 2022
Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?Marco Crocco, Antonio Verrico, Claudia Milanaccio, et al.
Virchows Archiv : an International Journal of Pathology|October 6, 2025
Superficially located CIC::DUX4-rearranged sarcomas in children: insights from a long-term survival case seriesGina Del Vecchio, Rita Alaggio, Alessandra Stracuzzi, et al.
Clinical Neuropathology|October 21, 2021
Cerebellar liponeurocytoma in an elderly patient: DNA methylation profiling as a helpful diagnostic toolHiba Alzoubi, Francesca Gianno, Yussuf Abuelhaija, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus BevacizumabMarina Fabbi, Delfina Costa, Daniela Russo, et al.
Haematologica|August 29, 2020
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokinesPaolo Giannoni, Cecilia Marini, Giovanna Cutrona, et al.
Neuro-Oncology|April 19, 2023
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activityFederica Barbieri, Adriana Bajetto, Irene Dellacasagrande, et al.
Cancers|May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 StudySara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugsVeronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
Future Oncology (London, England)|April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Future Oncology (London, England)|June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cancers|June 10, 2022
Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?Marco Crocco, Antonio Verrico, Claudia Milanaccio, et al.
Virchows Archiv : an International Journal of Pathology|October 6, 2025
Superficially located CIC::DUX4-rearranged sarcomas in children: insights from a long-term survival case seriesGina Del Vecchio, Rita Alaggio, Alessandra Stracuzzi, et al.
Clinical Neuropathology|October 21, 2021
Cerebellar liponeurocytoma in an elderly patient: DNA methylation profiling as a helpful diagnostic toolHiba Alzoubi, Francesca Gianno, Yussuf Abuelhaija, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus BevacizumabMarina Fabbi, Delfina Costa, Daniela Russo, et al.
Haematologica|August 29, 2020
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokinesPaolo Giannoni, Cecilia Marini, Giovanna Cutrona, et al.
Neuro-Oncology|April 19, 2023
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activityFederica Barbieri, Adriana Bajetto, Irene Dellacasagrande, et al.
Cancers|May 16, 2023
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 StudySara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 23, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugsVeronica Bensa, Hugo Lopes-Cardoso, Eleonora Ciampi, et al.
Future Oncology (London, England)|April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Future Oncology (London, England)|June 11, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Pageof 8